NNC0165-1875
Sources
registry, as of 2019-09-06Stale
https://clinicaltrials.gov/study/NCT03707990
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese. Overall status COMPLETED. Phases PHASE1. Lead sponsor Novo Nordisk A/S. Enrollment 88. Conditions Obesity and Overweight. The study is looking at possible new medicines for weight control in people with high body weight. The study looks at how the new medicines work in the body. The study consists of two parts. If participants take part in Part 1, they will either get a single dose of NNC0165-1875 o
ClinicalTrials.gov NCT03707990 protocol and results modules
registry, as of 2026-01-08Stale
https://clinicaltrials.gov/study/NCT04969939
A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity. Overall status COMPLETED. Phases PHASE2. Lead sponsor Novo Nordisk A/S. Enrollment 120. Conditions Obesity. The study is looking at a new medicine to help people lose weight. In this study participants will either get semaglutide and NNC0165-1875 or semaglutide and a "dummy" medicine (placebo). Which treatment participants get is decided by chance. Participants will get 2 injections pe
ClinicalTrials.gov NCT04969939 protocol and results modules